R
Ross L. Prentice
Researcher at Fred Hutchinson Cancer Research Center
Publications - 407
Citations - 37908
Ross L. Prentice is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Breast cancer & Women's Health Initiative. The author has an hindex of 94, co-authored 407 publications receiving 33619 citations. Previous affiliations of Ross L. Prentice include Argonne National Laboratory & Radiation Effects Research Foundation.
Papers
More filters
Journal ArticleDOI
Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study.
Carolyn J. Crandall,Kathleen M. Hovey,Chris Andrews,Jane A. Cauley,Marcia L. Stefanick,Chrisandra Shufelt,Ross L. Prentice,Andrew M. Kaunitz,Charles B. Eaton,Jean Wactawski-Wende,JoAnn E. Manson +10 more
TL;DR: The summary index of risks versus benefits was similar for oral CEE versus oral or transdermal E2-containing regimens, and Findings were similar among women with hysterectomy taking estrogen alone.
Journal ArticleDOI
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.
Kuanrong Li,Garnet L. Anderson,Vivian Viallon,Patrick Arveux,Marina Kvaskoff,Marina Kvaskoff,Agnès Fournier,Agnès Fournier,Vittorio Krogh,Rosario Tumino,María José Sánchez,Eva Ardanaz,Maria-Dolores Chirlaque,Antonio Agudo,David C. Muller,Todd Smith,Ioanna Tzoulaki,Timothy J. Key,Bas Bueno-de-Mesquita,Antonia Trichopoulou,Christina Bamia,Philippos Orfanos,Rudolf Kaaks,Anika Hüsing,Renée T. Fortner,Anne Zeleniuch-Jacquotte,Malin Sund,Christina C. Dahm,Kim Overvad,Kim Overvad,Dagfinn Aune,Elisabete Weiderpass,Isabelle Romieu,Elio Riboli,Marc J. Gunter,Laure Dossus,Ross L. Prentice,Pietro Ferrari +37 more
TL;DR: A model specifically predictive of ER+ tumor risk could be more applicable than an omnibus model in risk assessment for chemoprevention and may yield little improvement in BC risk prediction.
Journal ArticleDOI
Sodium Intake and Osteoporosis. Findings From the Women's Health Initiative
Laura D Carbone,Karen C. Johnson,Ying Huang,Mary Pettinger,Fridjtof Thomas,Jane A. Cauley,Carolyn J. Crandall,Lesley F. Tinker,Meryl S. LeBoff,Jean Wactawski-Wende,Monique Bethel,Monique Bethel,Wenjun Li,Ross L. Prentice +13 more
TL;DR: In this large, prospective, observational cohort study of postmenopausal women in the WHI, Cox proportional hazard regression models showed that sodium intake at or near recommended levels is not likely to impact bone metabolism.
Journal ArticleDOI
Discussion: On the role and analysis of secondary outcomes in clinical trials
TL;DR: In this article, the authors discuss the role of secondary clinical outcomes in monitoring for early trial stoppage in clinical trials, as well as the role that such outcomes may play in monitoring.
Journal ArticleDOI
Design issues in cohort studies.
TL;DR: This background, and a discussion of factors influencing cohort study power, provides a context to examine various cohort study design choices, including the choice of study population, the selection of cohort size and follow-up duration, cohort ascertainment and subsampling choices, and decisions concerning validation and reliability substudies.